MDK and breast cancer: Our results demonstrated that USP12 directly binds and deubiquitinate MDK, leading to the upregulation of MDK and the promotion of angiogenesis and metastasis, which suggests that USP12 is a key mediator of breast cancer metastasis and provides us with a possible opportunity for therapy against metastasis.